发明名称 |
USE OF ITK INHIBITORS FOR THE TREATMENT OF CANCER |
摘要 |
This invention relates generally to the use of ITK (IL-2 inducible T-cell kinase) inhibitors for the treatment of patients who have melanoma or other solid tumors. Applicants demonstrate that ITK lentiviral small hairpin RNA knockdowns and a small molecule inhibitor can each decrease the proliferation and migration of melanoma cell lines and a small molecule inhibitor can be used to inhibit the growth of melanomas in vivo. |
申请公布号 |
US2016000788(A1) |
申请公布日期 |
2016.01.07 |
申请号 |
US201314647354 |
申请日期 |
2013.11.26 |
申请人 |
The University of North Carolina at Chapel Hill |
发明人 |
Thomas Nancy;Dorsey Kathleen;Edmiston Sharon;Groben Pamela;Carson Craig |
分类号 |
A61K31/519;A61K31/4155;A61K31/4184;A61K31/4985;A61K31/426 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting the growth of a solid tumor in a subject which comprises administering an effective amount of a selective interleukin-2 inducible T-cell kinase (ITK) inhibitor to the subject. |
地址 |
Chapel Hill NC US |